Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The category continues attracting new entrants while facing evolving regulatory scrutiny, creating a dynamic market environment where platform differentiation increasingly centers on pricing structure, medication formulation options, and operational transparency regarding the separation between technology services and medical decision-making
The concern over compounded GLP-1s Typically, compounding pharmacies are not allowed to make copies of FDA-approved medications
Wade and Su, 2021)
Bristol Myers Squibb Bristol Myers Squibb engages in exploring innovative peptide therapeutics and combination treatments
US$ 24.61
US$ 21.91
US$ 27.73
US$ 27.48
US$ 26.16
US$ 21.41
US$ 21.82
US$ 25.99
US$ 23.47
US$ 27.77
US$ 23.38
US$ 26.57
